Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01671865 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy
A clinical trial of Facioscapulohumeral Muscular Dystrophy, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Active
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT01671865: Active study of Facioscapulohumeral Muscular Dystrophy, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
NCT01671865 is a study of Facioscapulohumeral Muscular Dystrophy that is active but no longer recruiting, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 75 participants, below the 1,500-participant average among 6 other Facioscapulohumeral Muscular Dystrophy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01671865, a study of Facioscapulohumeral Muscular Dystrophy, is active but no longer recruiting, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- ACTIVE NOT RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to identify and study changes in muscle in people with facioscapulohumeral muscular dystrophy using magnetic resonance imaging and spectroscopy.
Primary Outcome
Intramuscular fat infiltration on MRI
Conditions Studied
Study Locations (1)
Maryland
- Doris Leung - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2012-03 |
| Est. Completion | 2026-06 |
What the registry record for NCT01671865 still lists
NCT01671865 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,500-participant average among 6 other Facioscapulohumeral Muscular Dystrophy trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Facioscapulohumeral Muscular Dystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT01671865 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01671865 about?
NCT01671865 is a clinical study titled "Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy". The purpose of this research study is to identify and study changes in muscle in people with facioscapulohumeral muscular dystrophy using magnetic resonance imaging and spectroscopy.
What is the current status of trial NCT01671865?
This trial is currently active not recruiting. The enrollment target is 75 participants. The study started on 2012-03. Estimated completion is 2026-06.
What conditions does trial NCT01671865 study?
This clinical trial studies the following conditions: Facioscapulohumeral Muscular Dystrophy.
Who is sponsoring clinical trial NCT01671865?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01671865 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facioscapulohumeral Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
RECRUITING
-
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
RECRUITING
-
Biomarker Development for Muscular Dystrophies
RECRUITING
-
A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy
RECRUITING · Phase 1
-
BetterLife FSHD: A Patient-driven Health and Research Platform
RECRUITING
-
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia